Form D · Other
OVATION SCIENCE INC.
Vancouver, A1 · CIK 0001751058
Offering snapshot reported Apr 11, 2024 · SEC filing
- Reported sold
- $50K Offering amount: $100K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 28, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 11, 2024 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Aug 29, 2018 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-510359
Amount remaining to be sold represent amounts that may be received upon exercise of warrants
Source: Form D, filed Apr 11, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Logan Anderson | Director, Executive |
| Joan Chypyha | Director |
| Shane Dungey | Director |
| Ian Howard | Director |
| Terry Howlett | Director, Executive |
| Doreen Mc Morran | Director, Executive |
| David K Ryan | Director, Executive |
| Ronald Stern | Director |
Issuer details
Industry: Other (See others in industry)
Address:
1003 1166 Alberni Street
Vancouver, A1, V6E3Z2
Vancouver, A1, V6E3Z2